Remove 2016 Remove DEA Remove Policy
article thumbnail

Intoxicating Hemp Swindle

Project CBD

In response to its growing popularity, the DEA announced in 2016 that kratom would be placed in the restrictive Schedule I along with cannabis. However, the following year the DEA put off its decision pending further public commentary. Yet its advocates tout its ability to help wean users off opioids.

article thumbnail

Lunch & Learn Episode 6: Is Cannabis' "Accepted Medical Use" Political?

Americans for Safe Access

Watch as we explore the significance of the last 12 years in establishing cannabis' "currently accepted medical use" and learn why this matters!

DEA
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Court: DEA Must Explain Its Failure to Act Upon Pending Marijuana Cultivation Applications

NORML

A federal court has ordered the Drug Enforcement Administration to respond to a lawsuit charging the agency with failing to move forward with a 2016 policy to expand the total number of federally licensed marijuana cultivators. “[This filing is] asking the court for an order compelling the DEA to process our application.

DEA
article thumbnail

NORML Formally Responds to DEA’s Proposed Changes to Marijuana Cultivation Rules

NORML

As a result, the DEA has been encouraged for over a decade to expand the pool of federally licensed cannabis producers — a move that the agency has largely resisted. In 2016, the agency appeared to reconsider its longstanding policy, and publicly stated for the first time that it would consider additional applicants.

article thumbnail

DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action

NORML

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.

DEA
article thumbnail

NORML Says DEA’s Newly Proposed Bulk Cultivation Rules Are “Unduly Onerous, Expensive, and Impractical”

NORML

The DEA now estimates that, under the new rules, it may approve between three and 15 total applicants. ” He added, “Further, the DEA has an incredibly poor track record in this arena – having for years now promised to expedite and streamline this process, but failing to deliver.

article thumbnail

Justice Department Urged To Take “Immediate Action” On Marijuana Grow Applications

NORML

In August 2016, the US Drug Enforcement Administration announced in the US Federal Register that the agency was “adopting a new policy that is designed to increase the number of entities registered under the Controlled Substances Act to grow (manufacture) marijuana to supply legitimate researchers in the United States.”

DEA